Factors associated with testing for HIV and hepatitis C among behaviorally vulnerable men in Germany : a cross-sectional analysis upon enrollment into an observational cohort
© 2021. The Author(s)..
BACKGROUND: HIV and hepatitis C virus (HCV) have shared routes of transmission among men who have sex with men (MSM). Routine testing facilitates early diagnosis and treatment, thereby preventing morbidity and onward transmission. We evaluated factors associated with HIV and HCV testing in a behaviorally vulnerable cohort of predominantly MSM.
METHODS: From June 2018 through June 2019, the BRAHMS study enrolled adults at ten German outpatient clinics that serve gender and sexual minority populations. Participants completed behavioral questionnaires that captured prior experience with HIV and HCV testing. Multivariable robust Poisson regression was used to evaluate factors potentially associated with testing in the previous 6 months.
RESULTS: Among 1017 participants with median age 33 (interquartile range 28-39) years, 1001 (98.4%) reported any lifetime history of HIV testing and 787 (77.4%) reported any HCV testing, including 16 (1.6%) known to be living with HCV. Testing within the last 6 months was reported by 921 (90.6%) and 513 (50.4%) for HIV and HCV, respectively. Recent HIV testing was more common among participants with higher education level and recent HCV testing. Recent HCV testing was more common among participants with non-cisgender identity, lifetime history of illicit drug use, hepatitis B immunity or infection, and recent HIV testing.
CONCLUSION: Prior testing for HIV was common in this cohort, but interventions are needed to improve HCV risk stratification and access to testing. HIV testing infrastructure can be successfully leveraged to support HCV testing, but differentiated preventive care delivery is needed for some vulnerable populations.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
AIDS research and therapy - 18(2021), 1 vom: 16. Aug., Seite 52 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Crowell, Trevor A [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 17.09.2021 Date Revised 31.05.2022 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s12981-021-00378-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM329434268 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM329434268 | ||
| 003 | DE-627 | ||
| 005 | 20231225205119.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12981-021-00378-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1098.xml |
| 035 | |a (DE-627)NLM329434268 | ||
| 035 | |a (NLM)34399787 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Crowell, Trevor A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Factors associated with testing for HIV and hepatitis C among behaviorally vulnerable men in Germany |b a cross-sectional analysis upon enrollment into an observational cohort |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.09.2021 | ||
| 500 | |a Date Revised 31.05.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s). | ||
| 520 | |a BACKGROUND: HIV and hepatitis C virus (HCV) have shared routes of transmission among men who have sex with men (MSM). Routine testing facilitates early diagnosis and treatment, thereby preventing morbidity and onward transmission. We evaluated factors associated with HIV and HCV testing in a behaviorally vulnerable cohort of predominantly MSM | ||
| 520 | |a METHODS: From June 2018 through June 2019, the BRAHMS study enrolled adults at ten German outpatient clinics that serve gender and sexual minority populations. Participants completed behavioral questionnaires that captured prior experience with HIV and HCV testing. Multivariable robust Poisson regression was used to evaluate factors potentially associated with testing in the previous 6 months | ||
| 520 | |a RESULTS: Among 1017 participants with median age 33 (interquartile range 28-39) years, 1001 (98.4%) reported any lifetime history of HIV testing and 787 (77.4%) reported any HCV testing, including 16 (1.6%) known to be living with HCV. Testing within the last 6 months was reported by 921 (90.6%) and 513 (50.4%) for HIV and HCV, respectively. Recent HIV testing was more common among participants with higher education level and recent HCV testing. Recent HCV testing was more common among participants with non-cisgender identity, lifetime history of illicit drug use, hepatitis B immunity or infection, and recent HIV testing | ||
| 520 | |a CONCLUSION: Prior testing for HIV was common in this cohort, but interventions are needed to improve HCV risk stratification and access to testing. HIV testing infrastructure can be successfully leveraged to support HCV testing, but differentiated preventive care delivery is needed for some vulnerable populations | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
| 650 | 4 | |a Europe | |
| 650 | 4 | |a Hepatitis C virus | |
| 650 | 4 | |a Human immunodeficiency virus | |
| 650 | 4 | |a Screening practices | |
| 650 | 4 | |a Sexual and gender minorities | |
| 650 | 4 | |a Voluntary counseling and testing | |
| 700 | 1 | |a Qian, Haoyu |e verfasserin |4 aut | |
| 700 | 1 | |a Tiemann, Carsten |e verfasserin |4 aut | |
| 700 | 1 | |a Lehmann, Clara |e verfasserin |4 aut | |
| 700 | 1 | |a Boesecke, Christoph |e verfasserin |4 aut | |
| 700 | 1 | |a Stoehr, Albrecht |e verfasserin |4 aut | |
| 700 | 1 | |a Hartikainen, Jukka |e verfasserin |4 aut | |
| 700 | 1 | |a Esser, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Bickel, Markus |e verfasserin |4 aut | |
| 700 | 1 | |a Spinner, Christoph D |e verfasserin |4 aut | |
| 700 | 1 | |a Schneeweiß, Stephan |e verfasserin |4 aut | |
| 700 | 1 | |a Cordes, Christiane |e verfasserin |4 aut | |
| 700 | 1 | |a Brockmeyer, Norbert |e verfasserin |4 aut | |
| 700 | 1 | |a Jessen, Heiko |e verfasserin |4 aut | |
| 700 | 1 | |a Robb, Merlin L |e verfasserin |4 aut | |
| 700 | 1 | |a Michael, Nelson L |e verfasserin |4 aut | |
| 700 | 1 | |a Jansen, Klaus |e verfasserin |4 aut | |
| 700 | 1 | |a Streeck, Hendrik |e verfasserin |4 aut | |
| 700 | 0 | |a BRAHMS Study Team |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t AIDS research and therapy |d 2004 |g 18(2021), 1 vom: 16. Aug., Seite 52 |w (DE-627)NLM154648086 |x 1742-6405 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2021 |g number:1 |g day:16 |g month:08 |g pages:52 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12981-021-00378-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2021 |e 1 |b 16 |c 08 |h 52 | ||